期刊文献+

Smart scaffolds in bone tissue engineering: A systematic review of literature 被引量:16

Smart scaffolds in bone tissue engineering: A systematic review of literature
下载PDF
导出
摘要 AIM: To improve osteogenic differentiation and attachment of cells.METHODS: An electronic search was conducted inPub Med from January 2004 to December 2013. Studies which performed smart modifications on conventional bone scaffold materials were included. Scaffolds with controlled release or encapsulation of bioactive molecules were not included. Experiments which did not investigate response of cells toward the scaffold(cell attachment, proliferation or osteoblastic differentiation) were excluded. RESULTS: Among 1458 studies, 38 met the inclusion and exclusion criteria. The main scaffold varied extensively among the included studies. Smart modifications included addition of growth factors(group Ⅰ-11 studies), extracellular matrix-like molecules(group Ⅱ-13 studies) and nanoparticles(nano-HA)(group Ⅲ-17 studies). In all groups, surface coating was the most commonly applied approach for smart modification of scaffolds. In group I, bone morphogenetic proteins were mainly used as growth factor stabilized on polycaprolactone(PCL). In group Ⅱ, collagen 1 in combination with PCL, hydroxyapatite(HA) and tricalcium phosphate were the most frequent scaffolds used. In the third group, nano-HA with PCL and chitosan were used the most. As variable methods were used, a thorough and comprehensible compare between the results and approaches was unattainable.CONCLUSION: Regarding the variability in methodology of these in vitro studies it was demonstrated that smart modification of scaffolds can improve tissue properties. AIM To improve osteogenic differentiation and attachmentof cells.METHODS: An electronic search was conducted inPubMed from January 2004 to December 2013. Studieswhich performed smart modifications on conventionalbone scaffold materials were included. Scaffoldswith controlled release or encapsulation of bioactivemolecules were not included. Experiments which did notinvestigate response of cells toward the scaffold (cellattachment, proliferation or osteoblastic differentiation)were excluded.RESULTS: Among 1458 studies, 38 met the inclusion andexclusion criteria. The main scaffold varied extensivelyamong the included studies. Smart modificationsincluded addition of growth factors (group Ⅰ-11 studies),extracellular matrix-like molecules (group Ⅱ-13 studies)and nanoparticles (nano-HA) (group Ⅲ-17 studies). In allgroups, surface coating was the most commonly appliedapproach for smart modification of scaffolds. In group I,bone morphogenetic proteins were mainly used as growthfactor stabilized on polycaprolactone (PCL). In groupⅡ, collagen 1 in combination with PCL, hydroxyapatite(HA) and tricalcium phosphate were the most frequentscaffolds used. In the third group, nano-HA with PCL andchitosan were used the most. As variable methods wereused, a thorough and comprehensible compare betweenthe results and approaches was unattainable.CONCLUSION: Regarding the variability in methodologyof these in vitro studies it was demonstrated that smartmodification of scaffolds can improve tissue properties.
出处 《World Journal of Stem Cells》 SCIE CAS 2015年第3期657-668,共12页 世界干细胞杂志(英文版)(电子版)
关键词 BONE TISSUE engineering SCAFFOLD Growthfactor NANOPARTICLE EXTRACELLULAR MATRIX Bone tissue engineering Scaffold Growth factor Nanoparticle Extracellular matrix
  • 相关文献

参考文献76

  • 1Langer R, Vacanti JP. Tissue engineering. Science 1993; 260:920-926 [PMID: 8493529 DOI: 10.1126/science.8493529].
  • 2Khojasteh A, Behnia H, Dashti SG, Stevens M. Current trends in mesenchymal stem cell application in bone augmentation: a reviewof the literature. J Oral Maxillofac Surg 2012; 70: 972-982 [PMID:21763048 DOI: 10.1016/j.joms.2011.02.133].
  • 3Tabatabaei FS, Motamedian SR, Gholipour F, Khosraviani K,Khojasteh A. Craniomaxillofacial Bone Engineering by ScaffoldsLoaded with Stem Cells: A Systematic Review. J Den Sch 2012; 30:113-130.
  • 4Behnia H, Khoshzaban A, Zarinfar M, Mashhadi Abbas f,bahraminasab H, Khojasteh A. Histological Evaluation ofRegeneration in Rabbit Calvarial Bone Defects Using DemineralizedBone Matrix, Mesenchymal Stem Cells and Platelet Rich in GrowthFactors. J Dent Sch 2012; 30: 143-154.
  • 5Behnia H, Khojasteh A, Kiani MT, Khoshzaban A, Mashhadi AbbasF, Bashtar M, Dashti SG. Bone regeneration with a combination ofnanocrystalline hydroxyapatite silica gel, platelet-rich growth factor,and mesenchymal stem cells: a histologic study in rabbit calvaria.Oral Surg Oral Med Oral Pathol Oral Radiol 2013; 115: e7-15[PMID: 23312925 DOI: 10.1016/j.oooo.2011.09.034].
  • 6Khojasteh A, Eslaminejad MB, Nazarian H. Mesenchymal stemcells enhance bone regeneration in rat calvarial critical size defectsmore than platelete-rich plasma. Oral Surg Oral Med Oral PatholOral Radiol Endod 2008; 106: 356-362; discussion 363 [PMID:18424120 DOI: 10.1016/j.tripleo.2007.10.017].
  • 7Behnia H, Khojasteh A, Soleimani M, Tehranchi A, KhoshzabanA, Keshel SH, Atashi R. Secondary repair of alveolar clefts usinghuman mesenchymal stem cells. Oral Surg Oral Med Oral PatholOral Radiol Endod 2009; 108: e1-e6 [PMID: 19615638 DOI:10.1016/j.tripleo.2009.03.040].
  • 8Behnia H, Khojasteh A, Soleimani M, Tehranchi A, Atashi A.Repair of alveolar cleft defect with mesenchymal stem cellsand platelet derived growth factors: a preliminary report. JCraniomaxillofac Surg 2012; 40: 2-7 [PMID: 21420310 DOI:10.1016/j.jcms.2011.02.003].
  • 9Shayesteh YS, Khojasteh A, Soleimani M, Alikhasi M,Khoshzaban A, Ahmadbeigi N. Sinus augmentation using humanmesenchymal stem cells loaded into a beta-tricalcium phosphate/hydroxyapatite scaffold. Oral Surg Oral Med Oral Pathol OralRadiol Endod 2008; 106: 203-209 [PMID: 18424115 DOI: 10.1016/j.tripleo.2007.12.001].
  • 10Jafarian M, Eslaminejad MB, Khojasteh A, Mashhadi Abbas F,Dehghan MM, Hassanizadeh R, Houshmand B. Marrow-derivedmesenchymal stem cells-directed bone regeneration in the dogmandible: a comparison between biphasic calcium phosphate andnatural bone mineral. Oral Surg Oral Med Oral Pathol Oral RadiolEndod 2008; 105: e14-e24 [PMID: 18442730 DOI: 10.1016/j.tripleo.2008.01.010].

同被引文献67

引证文献16

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部